Evidence map›Paper›PMID 41477234›Full record

ArticleFrontiers in public health2025

Analysis of the effectiveness of improving the testing rate of pathogenicity specimens prior to the use of antibiotics in Shandong Province, 2014-2023.

Zhiyuan Chen, Jian Sun, Weiguang Li

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zhiyuan ChenDepartment of Infection Control, Provincial Hospital of Shandong First Medical University, Jinan, Shandong, China.
Jian SunDepartment of Infection Control, Provincial Hospital of Shandong First Medical University, Jinan, Shandong, China.
Weiguang LiDepartment of Infection Control, Provincial Hospital of Shandong First Medical University, Jinan, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To analyze the trend of pathogenic specimen detection rate before antibiotic treatment in inpatients in Shandong Province from 2014 to 2023 and to provide a scientific basis for optimizing antibiotic management. Methods: The time of antibiotic use and the time of pathogenic specimen collection for inpatients in each hospital were collected through the hospital information system, the test information system, and the mobile care system. The process data of specimen detection rate were calculated according to different time points: the pre-antibiotic treatment pathogenic detection rate, the detection rate within 12 h after antibiotic treatment, the detection rate within 24 h, and the detection rate before discharge. Results: The detection rate of pre-antibiotic therapy pathogenicity specimens among inpatients in Shandong Province from 2014 to 2023 showed an overall increasing trend from 7.67 to 38.38%, while the pre-discharge detection rate increased from 32.84 to 67.48%; both differences were statistically significant ( Conclusion: The detection rate of pre-antibiotic therapy pathogenicity specimens among inpatients in Shandong Province showed an increasing trend from 2014 to 2023, but the number of people tested only 12 h after antibiotic therapy is still high and so needs to be focused on. This could be achieved by improving hospital information systems and increasing training.

Indexed as

Anti-Bacterial AgentsSpecimen HandlingChinaHumansInpatientsAnti-Bacterial Agentsantibioticsinformation systemmanagementpathogenesisspecimen testing

Identifiers

PMID41477234
PMCPMC12748153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.